NCT05211505

Investigation of Efficacy and Tolerability of WO 2707, a MoistCream Cremolum, in Postmenopausal Women Suffering From Symptoms of Vaginal Dryness

Prospective, Open-label Trial Investigating the Efficacy and Tolerability of WO 2707, a MoistCream Cremolum, in Postmenopausal Women Suffering From Symptoms of Vaginal Dryness

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 79 (actual)
• Sponsor: Dr. August Wolff GmbH & Co. KG Arzneimittel · Industry
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The objective of the clinical investigation is to evaluate the efficacy and tolerability of WO 2707, a MoistCream Cremolum, with respect to the application in postmenopausal women with symptoms of vaginal dryness.

Conditions

• Vaginal Atrophy

Interventions

Type	Name	Description
DEVICE	WO 2707	Intravaginal application once daily for 1 week, then twice per week until visit 3 (day 38).

Timeline

• Start date: 2022-01-31
• Primary completion: 2022-03-24
• Completion: 2022-03-24
• First posted: 2022-01-27
• Last updated: 2022-04-27

Locations

1 site across 1 country: Germany